Pulmuone Corporate

017810 · KOSPI · Consumer Staples · SMALL CAP

Back to a net profit.

Pulmuone Corporate reported a subsidiary's consolidated results for FY2025: revenue of US$636M (+11.57% year on year), operating profit of US$23.2M (+31.34% year on year) and net income of US$4.38M (from a loss a year earlier).

Earnings(Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary))· FILED 2026-02-03· RCEPT 20260203800008

US$636MRevenue
+11.57%Revenue vs a year earlier
US$23.2MOperating profit

Converted at 1 USD ≈ ₩1,452.54 (filing-date rate, 2026-02-03 close)

What happened

Pulmuone Corporate reported a subsidiary's consolidated results for FY2025: revenue of US$636M (+11.57% year on year), operating profit of US$23.2M (+31.34% year on year) and net income of US$4.38M (from a loss a year earlier).

Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.

RevenueUS$636M
Revenue vs a year earlier+11.57%
Operating profitUS$23.2M
Net incomeUS$4.38M
PeriodFY2025 (consolidated)
Filed2026-02-03, Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary)
SourceDART rcept 20260203800008 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-02-03 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.